Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($) |
Preferred Stock [Member] |
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Treasury Stock, Common [Member] |
AOCI Attributable to Parent [Member] |
Retained Earnings [Member] |
Noncontrolling Interest [Member] |
Total |
|---|---|---|---|---|---|---|---|---|
| Beginning balance at Dec. 31, 2024 | $ 252 | $ 1,859,231 | $ 102,560,320 | $ (23,218) | $ (87,205,070) | $ 8,070 | $ 17,199,585 | |
| Balance, shares at Dec. 31, 2024 | 252,192 | 1,859,231,786 | ||||||
| Treasury stock Balance, shares at Dec. 31, 2024 | ||||||||
| Cumulative effect adjustment upon adoption of ASU 2023-08 | 148,346 | 148,346 | ||||||
| Common stock issued for services and other stock-based compensation | 387,634 | 387,634 | ||||||
| Common stock repurchased and held as treasury stock | $ (24,006) | (24,006) | ||||||
| Common stock repurchased and held as treasury stock, shares | 1,089,286 | |||||||
| Dividends | (204,835) | (204,835) | ||||||
| Net income (loss) | (685,866) | (1,987) | (687,853) | |||||
| Ending balance at Mar. 31, 2025 | $ 252 | $ 1,859,231 | 102,947,954 | $ (24,006) | (23,218) | (87,947,425) | 6,083 | 16,818,871 |
| Balance, shares at Mar. 31, 2025 | 252,192 | 1,859,231,786 | ||||||
| Treasury stock Balance, shares at Mar. 31, 2025 | 1,089,286 | |||||||
| Beginning balance at Dec. 31, 2025 | $ 252 | $ 1,860,375 | 104,110,876 | $ (246,898) | (23,218) | (96,789,073) | 12,600 | $ 8,924,914 |
| Balance, shares at Dec. 31, 2025 | 252,192 | 1,860,376,075 | ||||||
| Treasury stock Balance, shares at Dec. 31, 2025 | 12,489,710 | 12,489,710 | ||||||
| Common stock issued for services and other stock-based compensation | 403,370 | $ 403,370 | ||||||
| Common stock repurchased and held as treasury stock | $ (44,624) | (44,624) | ||||||
| Common stock repurchased and held as treasury stock, shares | 1,710,963 | |||||||
| Dividends | (204,835) | (204,835) | ||||||
| Net income (loss) | (3,892,031) | 2,963 | (3,889,068) | |||||
| Ending balance at Mar. 31, 2026 | $ 252 | $ 1,860,375 | $ 104,514,246 | $ (291,522) | $ (23,218) | $ (100,885,939) | $ 15,563 | $ 5,189,757 |
| Balance, shares at Mar. 31, 2026 | 252,192 | 1,860,376,075 | ||||||
| Treasury stock Balance, shares at Mar. 31, 2026 | 14,200,673 | 14,200,673 |
| X | ||||||||||
- Definition Amount of other increase (decrease) in additional paid in capital (APIC). No definition available.
|
| X | ||||||||||
- Definition Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of previously issued common shares repurchased by the issuing entity and held in treasury. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares that have been repurchased during the period and are being held in treasury. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|